Dean Elbe; BScPharm, PharmD, BCPP; Healthy Minds Centre, Children's & Women's Health Centre of British Columbia, Vancouver, BC, Canada; Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Tyler R. Black; BSc, MD, FRCPC; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Ian R. McGrane; PharmD, BCPS, BCPP; Skaggs School of Pharmacy, University of Montana, Missoula, MT, USA.Sabina Choi, BScPharm, PharmD, Victoria Primary Care Network, Island Health, Victoria, BC, Canada.

This book makes dry material more interesting and is pleasing to the eye... An abundance of new and old ideas, even for very savvy clinicians... An excellent purchase.;M. M. Relja and M. Sachdev in Journal of Child and Adolescent Psychopharmacology;A 'must-have' for those prescribing psychotropic medications in children and adolescents. It remains by far the most user-friendly and comprehensive handbook available for prescribers, teachers, students, and others working or interested in the field of child and adolescent psychopharmacology.; Pieter Joost van Wattum in Journal of Clinical Psychiatry; Authoritatively and exhaustively compiles currently available information in a user-friendly form. The aim of the Handbook is to be a source of 'fast facts' for the busy clinician...an aim it achieves splendidly.; M. Gittelman, Editor of International Journal of Mental Health; If you see children who are placed on psychotropic medications, this book clearly falls into your 'must-have' category.; J. C. Courtney in Child Neuropsychology;An impressive work that is informative, thorough, andorganized as a practical reference for prescribers. [It] not only provides detailed information onpsychotropic agents, but also contextualizes pharmacotherapy as part of a multi­modaltreatment approach [and] serves as a clinical guide that extends beyond theconfines of psychopharmacology. The clean and color-coded layout ensures easeof reference and an enjoyable reading experience. With its well-organizedstructure and layout, comprehensive content, and practical insights, it servesas a valuable tool for clinicians dedicated to providing quality care tochildren and adolescents with psychiatric disorders.Reviewed by Paul Slodovnick MD, LatifaJaafar MD, and Daniel A. Gorman MD, in J Can Acad Child Adolesc Psychiatry (July 2024), 33 (2) Child & adolescent psychiatrists crave up to date,evidence-based education, accessible at their fingertips, to ensure they aremaking the best treatment decisions for their patients. The fifth and mostrecent edition of the Clinical Handbook of Psychotropic Drugs for Childrenand Adolescents meets this need thoroughly, and with elegance. The online version of the text is easy tonavigate, allowing for “at the elbow” advice when in need of a quick referenceto assist in making treatment decisions. Child & adolescent psychiatrists,pharmacists, nursing, learners and providers will undoubtedly enjoy the updatedversion of the Clinical Handbook of Psychotropic Drugs for Children andAdolescents. The authors have been thoughtful in their revisions,expansions, and updates, fostering improved certainty and confidence forproviders and in turn patients and caregivers alike.Reviewed by Sabina Abidi MD and LauraMiller PharmD, in J Can Acad Child Adolesc Psychiatry (July 2024), 33(2).

• Prescribing Safely and Ethically to Children and AdolescentsPsychiatric Disorders in Children and AdolescentsAttention-Deficit/Hyperactivity Disorder (ADHD) * Major DepressiveDisorder (MDD) * Disruptive Mood Dysregulation Disorder (DMDD) * BipolarDisorder (BD) * Schizophrenia * ANXIETY DISORDERS * SeparationAnxiety Disorder * Generalized Anxiety Disorder (GAD) * Social AnxietyDisorder * Panic Disorder * Specific Phobia * Obsessive-Compulsive Disorder(OCD) * TRAUMA- AND STRESSOR-RELATED DISORDERS * PosttraumaticStress Disorder (PTSD) * TIC DISORDERS * Tourette's Disorder* Autism Spectrum Disorder (ASD) * DISRUPTIVE, IMPULSE-CONTROL,AND CONDUCT DISORDERS * Conduct Disorder (CD)Oppositional Defiant Disorder (ODD)Drugs for ADHDPsychostimulants * Atomoxetine * Comparison of Drugs for ADHD * 2Agonists * Augmentation Strategies in ADHDAntidepressantsSelective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine DopamineReuptake Inhibitor (NDRI) * Serotonin Norepinephrine ReuptakeInhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI)* Serotonin-1A Partial Agonist/Serotonin Reuptake Inhibitor (SPARI) *Serotonin Modulator and Stimulator (SMS) * Noradrenergic/SpecificSerotonergic Antidepressants (NaSSA) * Nonselective Cyclic Antidepressants* Monoamine Oxidase Inhibitors * Reversible Inhibitor ofMAO-A (RIMA) * Irreversible Monoamine Oxidase (A&B) Inhibitors(MAOIs) * Irreversible MAO-B Inhibitor * Effects of Antidepressants onNeurotransmitters/Receptors * Pharmacological Effects of Antidepressantson Neurotransmitters/Receptors * Frequency of AdverseReactions to Antidepressants at Therapeutic Doses * AntidepressantDoses and Pharmacokinetics * Switching Antidepressants * AntidepressantAugmentation StrategiesElectroconvulsive Therapy (ECT)Antipsychotics"Second-Generation" Antipsychotics/SGAs * "Third-Generation" Antipsychotic/TGA * "First-Generation" Antipsychotics/FGAs * Effectsof Antipsychotics on Neurotransmitters/Receptors* PharmacologicalEffects of Antipsychotics on Neurotransmitters/Receptors * Frequency(%) of Adverse Reactions to Antipsychotics at Therapeutic Doses *Antipsychotic Doses and Pharmacokinetics (Oral and Short-ActingInjections) * Comparison of Long-Acting IM Antipsychotics * SwitchingAntipsychotics * Antipsychotic Augmentation StrategiesAntipsychotic-Induced Extrapyramidal Side Effects (EPSE) and TheirManagementExtrapyramidal Side Effects of Antipsychotics * Treatment Options forExtrapyramidal Side Effects * Effects on Extrapyramidal Symptoms *Comparison of Agents for Treating Acute Extrapyramidal Side Effects* Doses and Pharmacokinetics of Agents for Treating Acute ExtrapyramidalSide EffectsAnxiolytic (Antianxiety) AgentsBenzodiazepines * Comparison of the Benzodiazepines * BuspironeHypnotics/SedativesComparison of Hypnotics/SedativesMood StabilizersLithium * Anticonvulsants * Comparison of Anticonvulsants * Frequencyof Adverse Reactions to Mood Stabilizers at Therapeutic DosesDrugs/Substances of AbuseAlcohol * Stimulants * Hallucinogens * Opioids * Inhalants/Aerosols* Sodium Oxybate (Gamma-Hydroxybutyrate - GHB) * Flunitrazepam(Rohypnol) * Nicotine/TobaccoTreatment of Substance Use DisordersDisulfiram * Acamprosate * Naltrexone * Methadone * Buprenorphine* Pharmacotherapy for Nicotine/Tobacco Use DependenceUnapproved Treatments of Psychiatric DisordersAdrenergic Agents * Cholinergic Agents * Dopaminergic Agents * GABAAgents/Anticonvulsants * Miscellaneous * NMDA AgentsNatural Health ProductsPharmacogenetic Information for Common Psychotropic DrugsManagement of Aggression in Children and AdolescentsGlossaryDrug Use in Pregnancy and Effects on Breast MilkPatient and Caregiver Information SheetsIndex of Drugs

Dean Elbe; BScPharm, PharmD, BCPP; Healthy Minds Centre, Children's & Women's Health Centre of British Columbia, Vancouver, BC, Canada; Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Tyler R. Black; BSc, MD, FRCPC; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Ian R. McGrane; PharmD, BCPS, BCPP; Skaggs School of Pharmacy, University of Montana, Missoula, MT, USA.Sabina Choi, BScPharm, PharmD, Victoria Primary Care Network, Island Health, Victoria, BC, Canada.

This book makes dry material more interesting and is pleasing to the eye... An abundance of new and old ideas, even for very savvy clinicians... An excellent purchase.;M. M. Relja and M. Sachdev in Journal of Child and Adolescent Psychopharmacology;A 'must-have' for those prescribing psychotropic medications in children and adolescents. It remains by far the most user-friendly and comprehensive handbook available for prescribers, teachers, students, and others working or interested in the field of child and adolescent psychopharmacology.; Pieter Joost van Wattum in Journal of Clinical Psychiatry; Authoritatively and exhaustively compiles currently available information in a user-friendly form. The aim of the Handbook is to be a source of 'fast facts' for the busy clinician...an aim it achieves splendidly.; M. Gittelman, Editor of International Journal of Mental Health; If you see children who are placed on psychotropic medications, this book clearly falls into your 'must-have' category.; J. C. Courtney in Child Neuropsychology;An impressive work that is informative, thorough, andorganized as a practical reference for prescribers. [It] not only provides detailed information onpsychotropic agents, but also contextualizes pharmacotherapy as part of a multi­modaltreatment approach [and] serves as a clinical guide that extends beyond theconfines of psychopharmacology. The clean and color-coded layout ensures easeof reference and an enjoyable reading experience. With its well-organizedstructure and layout, comprehensive content, and practical insights, it servesas a valuable tool for clinicians dedicated to providing quality care tochildren and adolescents with psychiatric disorders.Reviewed by Paul Slodovnick MD, LatifaJaafar MD, and Daniel A. Gorman MD, in J Can Acad Child Adolesc Psychiatry (July 2024), 33 (2) Child & adolescent psychiatrists crave up to date,evidence-based education, accessible at their fingertips, to ensure they aremaking the best treatment decisions for their patients. The fifth and mostrecent edition of the Clinical Handbook of Psychotropic Drugs for Childrenand Adolescents meets this need thoroughly, and with elegance. The online version of the text is easy tonavigate, allowing for “at the elbow” advice when in need of a quick referenceto assist in making treatment decisions. Child & adolescent psychiatrists,pharmacists, nursing, learners and providers will undoubtedly enjoy the updatedversion of the Clinical Handbook of Psychotropic Drugs for Children andAdolescents. The authors have been thoughtful in their revisions,expansions, and updates, fostering improved certainty and confidence forproviders and in turn patients and caregivers alike.Reviewed by Sabina Abidi MD and LauraMiller PharmD, in J Can Acad Child Adolesc Psychiatry (July 2024), 33(2).

• Prescribing Safely and Ethically to Children and AdolescentsPsychiatric Disorders in Children and AdolescentsAttention-Deficit/Hyperactivity Disorder (ADHD) * Major DepressiveDisorder (MDD) * Disruptive Mood Dysregulation Disorder (DMDD) * BipolarDisorder (BD) * Schizophrenia * ANXIETY DISORDERS * SeparationAnxiety Disorder * Generalized Anxiety Disorder (GAD) * Social AnxietyDisorder * Panic Disorder * Specific Phobia * Obsessive-Compulsive Disorder(OCD) * TRAUMA- AND STRESSOR-RELATED DISORDERS * PosttraumaticStress Disorder (PTSD) * TIC DISORDERS * Tourette's Disorder* Autism Spectrum Disorder (ASD) * DISRUPTIVE, IMPULSE-CONTROL,AND CONDUCT DISORDERS * Conduct Disorder (CD)Oppositional Defiant Disorder (ODD)Drugs for ADHDPsychostimulants * Atomoxetine * Comparison of Drugs for ADHD * 2Agonists * Augmentation Strategies in ADHDAntidepressantsSelective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine DopamineReuptake Inhibitor (NDRI) * Serotonin Norepinephrine ReuptakeInhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI)* Serotonin-1A Partial Agonist/Serotonin Reuptake Inhibitor (SPARI) *Serotonin Modulator and Stimulator (SMS) * Noradrenergic/SpecificSerotonergic Antidepressants (NaSSA) * Nonselective Cyclic Antidepressants* Monoamine Oxidase Inhibitors * Reversible Inhibitor ofMAO-A (RIMA) * Irreversible Monoamine Oxidase (A&B) Inhibitors(MAOIs) * Irreversible MAO-B Inhibitor * Effects of Antidepressants onNeurotransmitters/Receptors * Pharmacological Effects of Antidepressantson Neurotransmitters/Receptors * Frequency of AdverseReactions to Antidepressants at Therapeutic Doses * AntidepressantDoses and Pharmacokinetics * Switching Antidepressants * AntidepressantAugmentation StrategiesElectroconvulsive Therapy (ECT)Antipsychotics"Second-Generation" Antipsychotics/SGAs * "Third-Generation" Antipsychotic/TGA * "First-Generation" Antipsychotics/FGAs * Effectsof Antipsychotics on Neurotransmitters/Receptors* PharmacologicalEffects of Antipsychotics on Neurotransmitters/Receptors * Frequency(%) of Adverse Reactions to Antipsychotics at Therapeutic Doses *Antipsychotic Doses and Pharmacokinetics (Oral and Short-ActingInjections) * Comparison of Long-Acting IM Antipsychotics * SwitchingAntipsychotics * Antipsychotic Augmentation StrategiesAntipsychotic-Induced Extrapyramidal Side Effects (EPSE) and TheirManagementExtrapyramidal Side Effects of Antipsychotics * Treatment Options forExtrapyramidal Side Effects * Effects on Extrapyramidal Symptoms *Comparison of Agents for Treating Acute Extrapyramidal Side Effects* Doses and Pharmacokinetics of Agents for Treating Acute ExtrapyramidalSide EffectsAnxiolytic (Antianxiety) AgentsBenzodiazepines * Comparison of the Benzodiazepines * BuspironeHypnotics/SedativesComparison of Hypnotics/SedativesMood StabilizersLithium * Anticonvulsants * Comparison of Anticonvulsants * Frequencyof Adverse Reactions to Mood Stabilizers at Therapeutic DosesDrugs/Substances of AbuseAlcohol * Stimulants * Hallucinogens * Opioids * Inhalants/Aerosols* Sodium Oxybate (Gamma-Hydroxybutyrate - GHB) * Flunitrazepam(Rohypnol) * Nicotine/TobaccoTreatment of Substance Use DisordersDisulfiram * Acamprosate * Naltrexone * Methadone * Buprenorphine* Pharmacotherapy for Nicotine/Tobacco Use DependenceUnapproved Treatments of Psychiatric DisordersAdrenergic Agents * Cholinergic Agents * Dopaminergic Agents * GABAAgents/Anticonvulsants * Miscellaneous * NMDA AgentsNatural Health ProductsPharmacogenetic Information for Common Psychotropic DrugsManagement of Aggression in Children and AdolescentsGlossaryDrug Use in Pregnancy and Effects on Breast MilkPatient and Caregiver Information SheetsIndex of Drugs

Dean Elbe; BScPharm, PharmD, BCPP; Healthy Minds Centre, Children's & Women's Health Centre of British Columbia, Vancouver, BC, Canada; Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Tyler R. Black; BSc, MD, FRCPC; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Ian R. McGrane; PharmD, BCPS, BCPP; Skaggs School of Pharmacy, University of Montana, Missoula, MT, USA.Sabina Choi, BScPharm, PharmD, Victoria Primary Care Network, Island Health, Victoria, BC, Canada.

This book makes dry material more interesting and is pleasing to the eye... An abundance of new and old ideas, even for very savvy clinicians... An excellent purchase.;M. M. Relja and M. Sachdev in Journal of Child and Adolescent Psychopharmacology;A 'must-have' for those prescribing psychotropic medications in children and adolescents. It remains by far the most user-friendly and comprehensive handbook available for prescribers, teachers, students, and others working or interested in the field of child and adolescent psychopharmacology.; Pieter Joost van Wattum in Journal of Clinical Psychiatry; Authoritatively and exhaustively compiles currently available information in a user-friendly form. The aim of the Handbook is to be a source of 'fast facts' for the busy clinician...an aim it achieves splendidly.; M. Gittelman, Editor of International Journal of Mental Health; If you see children who are placed on psychotropic medications, this book clearly falls into your 'must-have' category.; J. C. Courtney in Child Neuropsychology;An impressive work that is informative, thorough, andorganized as a practical reference for prescribers. [It] not only provides detailed information onpsychotropic agents, but also contextualizes pharmacotherapy as part of a multi­modaltreatment approach [and] serves as a clinical guide that extends beyond theconfines of psychopharmacology. The clean and color-coded layout ensures easeof reference and an enjoyable reading experience. With its well-organizedstructure and layout, comprehensive content, and practical insights, it servesas a valuable tool for clinicians dedicated to providing quality care tochildren and adolescents with psychiatric disorders.Reviewed by Paul Slodovnick MD, LatifaJaafar MD, and Daniel A. Gorman MD, in J Can Acad Child Adolesc Psychiatry (July 2024), 33 (2) Child & adolescent psychiatrists crave up to date,evidence-based education, accessible at their fingertips, to ensure they aremaking the best treatment decisions for their patients. The fifth and mostrecent edition of the Clinical Handbook of Psychotropic Drugs for Childrenand Adolescents meets this need thoroughly, and with elegance. The online version of the text is easy tonavigate, allowing for “at the elbow” advice when in need of a quick referenceto assist in making treatment decisions. Child & adolescent psychiatrists,pharmacists, nursing, learners and providers will undoubtedly enjoy the updatedversion of the Clinical Handbook of Psychotropic Drugs for Children andAdolescents. The authors have been thoughtful in their revisions,expansions, and updates, fostering improved certainty and confidence forproviders and in turn patients and caregivers alike.Reviewed by Sabina Abidi MD and LauraMiller PharmD, in J Can Acad Child Adolesc Psychiatry (July 2024), 33(2).

• Prescribing Safely and Ethically to Children and AdolescentsPsychiatric Disorders in Children and AdolescentsAttention-Deficit/Hyperactivity Disorder (ADHD) * Major DepressiveDisorder (MDD) * Disruptive Mood Dysregulation Disorder (DMDD) * BipolarDisorder (BD) * Schizophrenia * ANXIETY DISORDERS * SeparationAnxiety Disorder * Generalized Anxiety Disorder (GAD) * Social AnxietyDisorder * Panic Disorder * Specific Phobia * Obsessive-Compulsive Disorder(OCD) * TRAUMA- AND STRESSOR-RELATED DISORDERS * PosttraumaticStress Disorder (PTSD) * TIC DISORDERS * Tourette's Disorder* Autism Spectrum Disorder (ASD) * DISRUPTIVE, IMPULSE-CONTROL,AND CONDUCT DISORDERS * Conduct Disorder (CD)Oppositional Defiant Disorder (ODD)Drugs for ADHDPsychostimulants * Atomoxetine * Comparison of Drugs for ADHD * 2Agonists * Augmentation Strategies in ADHDAntidepressantsSelective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine DopamineReuptake Inhibitor (NDRI) * Serotonin Norepinephrine ReuptakeInhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI)* Serotonin-1A Partial Agonist/Serotonin Reuptake Inhibitor (SPARI) *Serotonin Modulator and Stimulator (SMS) * Noradrenergic/SpecificSerotonergic Antidepressants (NaSSA) * Nonselective Cyclic Antidepressants* Monoamine Oxidase Inhibitors * Reversible Inhibitor ofMAO-A (RIMA) * Irreversible Monoamine Oxidase (A&B) Inhibitors(MAOIs) * Irreversible MAO-B Inhibitor * Effects of Antidepressants onNeurotransmitters/Receptors * Pharmacological Effects of Antidepressantson Neurotransmitters/Receptors * Frequency of AdverseReactions to Antidepressants at Therapeutic Doses * AntidepressantDoses and Pharmacokinetics * Switching Antidepressants * AntidepressantAugmentation StrategiesElectroconvulsive Therapy (ECT)Antipsychotics"Second-Generation" Antipsychotics/SGAs * "Third-Generation" Antipsychotic/TGA * "First-Generation" Antipsychotics/FGAs * Effectsof Antipsychotics on Neurotransmitters/Receptors* PharmacologicalEffects of Antipsychotics on Neurotransmitters/Receptors * Frequency(%) of Adverse Reactions to Antipsychotics at Therapeutic Doses *Antipsychotic Doses and Pharmacokinetics (Oral and Short-ActingInjections) * Comparison of Long-Acting IM Antipsychotics * SwitchingAntipsychotics * Antipsychotic Augmentation StrategiesAntipsychotic-Induced Extrapyramidal Side Effects (EPSE) and TheirManagementExtrapyramidal Side Effects of Antipsychotics * Treatment Options forExtrapyramidal Side Effects * Effects on Extrapyramidal Symptoms *Comparison of Agents for Treating Acute Extrapyramidal Side Effects* Doses and Pharmacokinetics of Agents for Treating Acute ExtrapyramidalSide EffectsAnxiolytic (Antianxiety) AgentsBenzodiazepines * Comparison of the Benzodiazepines * BuspironeHypnotics/SedativesComparison of Hypnotics/SedativesMood StabilizersLithium * Anticonvulsants * Comparison of Anticonvulsants * Frequencyof Adverse Reactions to Mood Stabilizers at Therapeutic DosesDrugs/Substances of AbuseAlcohol * Stimulants * Hallucinogens * Opioids * Inhalants/Aerosols* Sodium Oxybate (Gamma-Hydroxybutyrate - GHB) * Flunitrazepam(Rohypnol) * Nicotine/TobaccoTreatment of Substance Use DisordersDisulfiram * Acamprosate * Naltrexone * Methadone * Buprenorphine* Pharmacotherapy for Nicotine/Tobacco Use DependenceUnapproved Treatments of Psychiatric DisordersAdrenergic Agents * Cholinergic Agents * Dopaminergic Agents * GABAAgents/Anticonvulsants * Miscellaneous * NMDA AgentsNatural Health ProductsPharmacogenetic Information for Common Psychotropic DrugsManagement of Aggression in Children and AdolescentsGlossaryDrug Use in Pregnancy and Effects on Breast MilkPatient and Caregiver Information SheetsIndex of Drugs